RecruitingNCT04662918

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding: A Prospective, International Multicenter, Observational Study


Sponsor

Xingshun Qi

Enrollment

3,000 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Acute gastrointestinal bleeding is potentially lethal in liver cirrhosis. Accurate assessment of prognosis is critical in a timely fashion. A novel model, CAGIB score, has been developed based on our Chinese multicenter retrospective study. Now, a prospective, international multicenter, observational study will be performed to further compare the performance of CAGIB versus Child-Pugh and MELD scores for evaluating the in-hospital mortality of patients with liver cirrhosis and acute gastrointestinal bleeding.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with gastrointestinal bleeding. The study is currently recruiting participants at 23 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(23)

The Wright Center for Graduate Medical Education, 501 S. Washington Avenue

Scranton, Pennsylvania, United States

São Paulo State University (UNESP), Botucatu Medical School

São Paulo, São Paulo, Brazil

Beijing Youan Hospital, Capital Medical University

Beijing, Beijing Municipality, China

The Seventh Medical Center of Chinese PLA General Hospital

Beijing, Beijing Municipality, China

First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

The Six People's Hospital of Dalian

Dalian, Liaoning, China

Air Force Hospital of Northern Theater Command

Shenyang, Liaoning, China

General Hospital of Northern Theater Command

Shenyang, Liaoning, China

The First Hospital of China Medical University

Shenyang, Liaoning, China

The Six People's Hospital of Shenyang

Shenyang, Liaoning, China

Tangdu Hospital, Fourth Military Medical University,

Xi'an, Shaanxi, China

The First Affiliated Hospital of Xi'an Jiao Tong University

Xi'an, Shaanxi, China

The Second Affiliated Hospital of Xi'an Jiao Tong University

Xi'an, Shaanxi, China

Xi'an Central Hospital

Xi'an, Shaanxi, China

Shandong Provincial Hospital

Jinan, Shandong, China

Cathay General Hospital, Fu-Jen Catholic University School of Medicine

Taibei, Taiwan, China

Charité University Medical Center

Berlin, State of Berlin, Germany

Ernakulam Medical Center

Kochi, Kochi, India

Azienda di Rilievo Nazionale ad Alta Specializzazione Civico-Di Cristina-Benfratelli

Palermo, Palermo, Italy

National Autonomous University of Mexico

Mexico City, Mexico City, Mexico

Bezmialem Vakif University

Istanbul, Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04662918


Related Trials